Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS

Priya Jhelum1, Stephanie Zandee2,3, Fari Ryan1

  • 1Centre for Research in Neuroscience and BRaIN Program, Research Institute of the McGill University Health Centre (RI-MUHC), Livingston Hall, Room L7-210, 1650 Cedar Ave., Montreal, QC, H3G 1A4, Canada.

Insights

Ferroptosis, a cell death pathway involving iron and lipid peroxidation, is implicated in chronic experimental autoimmune encephalomyelitis (CH-EAE) and secondary progressive multiple sclerosis (SPMS). Inhibiting ferroptosis improved CH-EAE outcomes, suggesting its therapeutic potential.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Ferroptosis is a regulated cell death pathway driven by iron-dependent lipid peroxidation.
  • Oxidative stress and iron deposition are implicated in progressive multiple sclerosis (MS).
  • Experimental autoimmune encephalomyelitis (EAE) models are used to study MS pathogenesis.

Purpose of the Study:

  • To investigate the role of ferroptosis in chronic EAE (CH-EAE), a mouse model for MS.
  • To examine ferroptosis markers and therapeutic interventions in CH-EAE and human SPMS.

Main Methods:

  • Assessed mRNA and protein levels of ferroptosis-related genes and proteins in CH-EAE.
  • Analyzed iron metabolism markers, antioxidant pathways, and lipid peroxidation.
  • Treated CH-EAE mice with a ferroptosis inhibitor.
  • Examined autopsy tissue from SPMS patients.

Main Results:

  • CH-EAE showed altered ferroptosis gene expression and increased iron importers, heme oxygenase-1, and ferritin.
  • Nuclear receptor coactivator 4 (NCOA4) expression increased, correlating with redox-active iron and lipid peroxidation.
  • Antioxidant pathways were reduced in CH-EAE.
  • Ferroptosis inhibition improved CH-EAE function and pathology.
  • SPMS tissues showed NCOA4 expression in macrophages and oligodendrocytes near iron-laden cells.

Conclusions:

  • Ferroptosis plays a significant role in the pathogenesis of CH-EAE.
  • NCOA4-mediated ferritinophagy contributes to iron release and ferroptosis in CH-EAE and SPMS.
  • Targeting ferroptosis may offer a therapeutic strategy for progressive MS.